AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Stem cells: progress in research and edging towards the clinical setting
Authors: Stanworth, SJ Newland, AC
Citation: Sj. Stanworth et Ac. Newland, Stem cells: progress in research and edging towards the clinical setting, CLIN MED, 1(5), 2001, pp. 378-382
Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy
Authors: Liu, KZ Jia, L Kelsey, SM Newland, AC Mantsch, HH
Citation: Kz. Liu et al., Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy, APOPTOSIS, 6(4), 2001, pp. 269-278
Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma
Authors: McBride, NC Cavenagh, JD Ward, MC Grant, I Schey, S Gray, A Hughes, A Mills, MJ Cervi, P Newland, AC Kelsey, SM
Citation: Nc. Mcbride et al., Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma, LEUK LYMPH, 42(1-2), 2001, pp. 89-98
Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura
Authors: Newland, AC Burton, I Cavenagh, JD Copplestone, A Dolan, G Houghton, J Reilly, T
Citation: Ac. Newland et al., Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura, TRANSFUS M, 11(1), 2001, pp. 37-44
Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis
Authors: Jia, L Patwari, Y Srinivasula, SM Newland, AC Fernandes-Alnemri, T Alnemri, ES Kelsey, SM
Citation: L. Jia et al., Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis, ONCOGENE, 20(35), 2001, pp. 4817-4826
8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNF alpha-induced apoptosis is via inactivation of NF-kappa B
Authors: Yin, YZ Allen, PD Jia, L Kelsey, SM Newland, AC
Citation: Yz. Yin et al., 8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNF alpha-induced apoptosis is via inactivation of NF-kappa B, LEUK RES, 25(5), 2001, pp. 423-431
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells
Authors: Jia, L Srinivasula, SM Liu, FT Newland, AC Fernandes-Alnemri, T Alnemri, ES Kelsey, SM
Citation: L. Jia et al., Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells, BLOOD, 98(2), 2001, pp. 414-421
c-IAP1 blocks TNF alpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells
Authors: Partheniou, F Kelsey, SM Srinivasula, SM Newland, AC Alnemri, ES Jia, L
Citation: F. Partheniou et al., c-IAP1 blocks TNF alpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells, BIOC BIOP R, 287(1), 2001, pp. 181-189
TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax
Authors: Jia, L Patwari, Y Kelsey, SM Newland, AC
Citation: L. Jia et al., TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax, BIOC BIOP R, 283(5), 2001, pp. 1037-1045
Apaf-1XL is an inactive isoform compared with Apaf-1L
Authors: Fu, WN Kelsey, SM Newland, AC Jia, L
Citation: Wn. Fu et al., Apaf-1XL is an inactive isoform compared with Apaf-1L, BIOC BIOP R, 282(1), 2001, pp. 268-272
Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
Authors: Jenner, MJ Micallef, INM Rohatiner, AZ Kelsey, SM Newland, AC Cavenagh, JD
Citation: Mj. Jenner et al., Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide, MED ONCOL, 17(4), 2000, pp. 333-336
Platelet products, where to?
Authors: Duguid, JKM Newland, AC
Citation: Jkm. Duguid et Ac. Newland, Platelet products, where to?, TRANSFUS SC, 22(1-2), 2000, pp. 93-97
A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma
Authors: Linch, DC Smith, P Hancock, BW Hoskin, PJ Cunningham, DC Newland, AC Milligan, D Stevenson, PA Wood, JK Maclennan, KA Hudson, BV Hudson, GV Gregory, WM
Citation: Dc. Linch et al., A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma, ANN ONCOL, 11, 2000, pp. 87-90
Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints
Authors: Ketley, NJ Allen, PD Kelsey, SM Newland, AC
Citation: Nj. Ketley et al., Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints, LEUKEMIA, 14(4), 2000, pp. 620-628
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Authors: Shamash, J O'Doherty, CA Oliver, RTD Kelsey, S Gupta, RK Gallagher, CJ Newland, AC Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin
Authors: Rhoades, CJ Williams, MA Kelsey, SM Newland, AC
Citation: Cj. Rhoades et al., Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin, BLOOD REV, 14(1), 2000, pp. 14-30
Autologous transplantation with Philadelphia-negative progenitor cells forpatients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon
Authors: McBride, NC Cavenagh, JD Newland, AC Lillington, DM Murrell, C Kelsey, SM
Citation: Nc. Mcbride et al., Autologous transplantation with Philadelphia-negative progenitor cells forpatients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon, BONE MAR TR, 26(11), 2000, pp. 1165-1172
Flow cytometric analysis of different adhesion molecules expression on circulating CD14(-) and CB64(-) human dendritic cell precursors
Authors: Macey, MG Jawad, N McCarthy, DA Newland, AC Brown, KA
Citation: Mg. Macey et al., Flow cytometric analysis of different adhesion molecules expression on circulating CD14(-) and CB64(-) human dendritic cell precursors, IMMUNOBIOL, 202(1), 2000, pp. 59-67
Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets
Authors: Williams, MA Newland, AC Kelsey, SM
Citation: Ma. Williams et al., Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets, LEUK RES, 24(4), 2000, pp. 317-330
Multiple myeloma and immune thrombocytopenia
Authors: Gupta, V Hegde, UM Parameswaran, R Newland, AC
Citation: V. Gupta et al., Multiple myeloma and immune thrombocytopenia, CLIN LAB H, 22(4), 2000, pp. 239-242
Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immunesurveillance
Authors: Wu, YL Jiang, XR Lillington, DM Newland, AC Kelsey, SM
Citation: Yl. Wu et al., Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immunesurveillance, BR J HAEM, 111(3), 2000, pp. 807-816
Angiogenesis and angiogenic mediators in haematological malignancies
Authors: Mangi, MH Newland, AC
Citation: Mh. Mangi et Ac. Newland, Angiogenesis and angiogenic mediators in haematological malignancies, BR J HAEM, 111(1), 2000, pp. 43-51
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha
Authors: Yin, YZ Allen, PD Jia, L Macey, MG Kelsey, SM Newland, AC
Citation: Yz. Yin et al., Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha, BR J HAEM, 108(3), 2000, pp. 565-573
The United Kingdom Childhood Cancer Study: objectives, materials and methods
Authors: Boulton, A Boyd, P Cheng, KK Cook, J Gilman, EA Lunt, D Mahler, H Walker, C Wardroper, M Darbyshire, PJ Hill, FGH Mann, JR Morland, B Raafat, F Stevens, MCG Ahmed, A Amos, P Bone, V Bonney, S Bray, M Cambouropoulos, P Cook, S Day, N Elkins, S Hensel, F Lucas, P Pettinger, J Pugsley, M Ruja, E Skinner, J Williams, D Braodbent, V Williams, M Alcock, M Bell, K Buchan, M Cartwright, R Cusack, H Fear, N Griffiths, S Jarvis, J Johnson, P Kane, E Law, G Moorman, A Prajapati, J Roberts, P Roman, E Simpson, J Sinclair, V Staines, A Thackrah, C Thistlethwaite, S Waller, B Bailey, C Kinsey, S Lewis, I Picton, S Squire, R Taylor, R Beck, JM Doran, RML Livingston, JH Van Hille, P Beddis, I Cameron, MM Craft, A Hale, J Kernahan, J Reid, M Windebank, K Pearson, A Skinner, R Marks, S Achilles, J Alam, S Birch, JM Blair, V Buckley, B Clarkson, M Eden, OB Howell, S Kellaway, C Lashford, L Leeke, S Leggett, P Murphy, AV O'Rorke, C Panton, S Paxon, J Pots, H Roberts, C Rothwell, J Stephenson, W Whelpton, B Caswell, M McDowell, H Pizer, BL Gattamaneri, R Brock, J Kelsey, AM Stevens, R Will, A Brennan, B Brydon, J Dodds, C Findlay, E Finucane, J Fraser, J Harkness, E Heary, A Hunter, N Juszczak, E Lang, M Lapsley, E McArthur, A MacCalman, A McKinney, PA Proudfoot, K Smith, C Smith, K Stockton, D Thomson, CS Vickers, R Wilkie, R King, D Mackinlay, G Shaw, P Thomas, A Wallace, H Carachi, R Gibson, BS Simpson, E Cruickshank, G Hide, TAH Gregor, A Steers, AJW Barrett, A Hamblen, DL Kaye, SB Mackie, R Allen, A Jones, AA Beeby, S Bignall, V Breeze, L Deacon, J MacDonald, M Matthews, F Meggitt, C Peto, J Sharpe, E Spencer, C Swales, J Thorne, M Trowbridge, P Webster-King, J Williams, E Bell, BA Johnston, FG Marsh, HT Uttley, D Bartlett, J Evans, A Gullan, RW Glaser, MG Peterson, D Southcott, BM Cavanagh, N Pearl, K Scott, D Darby, CW Chessels, J Evans, J Gaze, M Hann, IM Harkness, W Hayward, R Michalski, A Passmore, J Phillips, M Pritchard, J Clark, KGA MacDonald, EA Neville, BGR Robb, SA Robinson, RO Hardwidge, C Padgham, N Lobo, VJ Keen, C Hindmarsh, PC Kilby, AM Souhami, RL Tuft, S Thomas, RM Ward, P Scott, M Hoffbrand, AV Prentice, HG Gutteridge, CG Newland, AC Brada, M Henk, JM Meller, S Pinkerton, R Jones, KP Cannon, S Murrell, DS Hungerford, JL Kingston, JE Plowman, PN Young, B Ball, SE Capps, SNJ Davies, EG Holmes, SJK Carr, R Mercer, DM Smith, MA Andrews, VE Hughes, RG Ansell, P Baker, K Beral, V Black, J Boon, S Burge, C Burge, F Cliff, A Deciaccio, D Dorman, P Heydon, F Langley, N Pelerin, M Roemmele, J Sayers, K Townshend, P Harman, S Loftus, J Roth, S Lee, B Buchdahl, R Dunger, DB Mitchell, C Moncrieff, MKM Tam, PKH Wheeler, K Reiser, J Joss, V Moir, DJ Darmady, J Daish, P Liberman, MM Al-Izzi, MS Adams, CBT Kerr, RSC Teddy, PJ Barton, CJ Newman, CL Gabriel, CM O'Hea, M Sherrin, S Watson, A Douek, E Connell, JA Kelly, S Beswick, A Eldridge, B Elwood, P Hughes, J Phillips, M Webb, D Alexander, FE Bennett-Lloyd, B Davis, A Dunn, R Little, J Longdon, S Mitchell, M Muir, S Sturitis, J Kennedy, C Kohler, J Lang, D Radford, M Foreman, N Foot, A Mott, M Noblett, H Oakhill, A Sandeman, D Baumer, J Ward, P McNinch, A Gilbertson, N Bosley, A Richardson, S Challacombe, D French, T Bate, L Chilvers, CED Faulkner, G Hawtin, P Jenkinson, C Kelham, P Mackie, I Mackie, M Muir, KR O'Dwyer, J Williams, A Nelson, C Howarth, C Madi, M Shannon, R Forman, K Hewitt, M Punt, J Walker, D Gerrard, M Lilleyman, JS Vora, A Draper, G Harrison, C Doll, R Richards, S Ayres, M Carter, R Dearden, SP Hussain, A Kennedy, J Ravetto, P Ruprai, A Taylor, GM Taylor, J Watson, PD Colman, SM Greaves, MF Price, CM Goodhead, DT Allen, S Bartlett, D Blackwell, RP Fry, F Maslanyj, M Mee, T Miles, J Adams, G
Citation: A. Boulton et al., The United Kingdom Childhood Cancer Study: objectives, materials and methods, BR J CANC, 82(5), 2000, pp. 1073-1102
Risultati: 1-25 | 26-43